Literature DB >> 4046619

Surgical management of effusive pericardial disease. Influence of extent of pericardial resection on clinical course.

J M Piehler, J R Pluth, H V Schaff, G K Danielson, T A Orszulak, F J Puga.   

Abstract

Surgical drainage for effusive pericardial disease is usually accompanied by pericardial resection to obtain tissue for analysis and to lessen the chance of recurrent effusion or late constriction. The purpose of this study was to determine the relationship between the extent of resection and the development of late complications. From 1960 through 1983, 145 patients with pure pericardial effusive disease underwent operative drainage. The effusions were malignant in 72 patients (49.7%) and benign in 73 (50.3%). The patients were divided into three groups according to the extent of resection: complete in 72 patients (49.7%), partial in 36 (24.8%), and window in 37 (25.5%). The 30 day mortality was 19.4% for patients with malignant effusions and 5.5% for those with benign effusions (p less than 0.05). All survivors had immediate improvement in symptoms. The actuarial 1 year survival rate was 23.4% (mean 4.2 months) for patients with malignant disease and 85.6% for patients with idiopathic effusions (p less than 0.001). Survival was not influenced by the extent of resection. Fifteen patients (10.3%) had late constriction or recurrent effusion. Six of these required reoperation, all after having had a window procedure. Actuarial probability of reoperation or late complication was greater with window procedures than other resections, both for all patients (p = 0.0001) and for those with benign disease (p = 0.0001). Transthoracic complete pericardiectomy is the procedure of choice for effusive pericardial disease. Subxiphoid drainage has immediate advantages for selected patients but has a statistically greater chance of late complications.

Entities:  

Mesh:

Year:  1985        PMID: 4046619

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  23 in total

1.  Laparoscopic transabdominal pericardial window: new standard in the treatment of recurrent pericardial effusion complicated by cardiac tamponade.

Authors:  E Totté; R Hee; P Brabant; B Wollaert; E Gheuens; S Declerck; J Leys; G Pelgrims; T Dieudonné; F Oei; M Vandermotte
Journal:  Surg Endosc       Date:  2001-12-10       Impact factor: 4.584

2.  Pericardial Effusion and Tamponade.

Authors: 
Journal:  Curr Treat Options Cardiovasc Med       Date:  1999-06

3.  Cardiac tamponade as a sequela to ventriculoatrial shunting for congenital hydrocephalus.

Authors:  Ahmed El-Eshmawi; Uvie Onakpoya; Ibrahim Khadragui
Journal:  Tex Heart Inst J       Date:  2009

4.  Percutaneous balloon pericardiostomy for non-surgical management of recurrent pericardial tamponade: a case report.

Authors:  Z D Hajduczok; D W Ferguson
Journal:  Intensive Care Med       Date:  1991       Impact factor: 17.440

Review 5.  Surgery for pericardial disease.

Authors:  Yang Hyun Cho; Hartzell V Schaff
Journal:  Heart Fail Rev       Date:  2013-05       Impact factor: 4.214

6.  Pericardiocentesis and systemic cytotoxic chemotherapy in the management of cardiac tamponade secondary to disseminated breast carcinoma.

Authors:  S Ramakrishnan; A J Marshall; J G Pickard; C J Tyrrell
Journal:  Br Heart J       Date:  1988-08

7.  Pericardial effusion in patients with cancer: outcome with contemporary management strategies.

Authors:  R J Laham; D J Cohen; R E Kuntz; D S Baim; B H Lorell; M Simons
Journal:  Heart       Date:  1996-01       Impact factor: 5.994

Review 8.  Modern approaches and use of surgical treatment for pericardial disease.

Authors:  Edward P Chen; Joseph I Miller
Journal:  Curr Cardiol Rep       Date:  2002-01       Impact factor: 2.931

Review 9.  Palliative treatment of malignant pericardial effusion: report of two cases and a review of the literature.

Authors:  A Sharma; R Kamble; L Kumar; B Bhargava; B M Biswal; V Kochupillai
Journal:  Support Care Cancer       Date:  1996-07       Impact factor: 3.603

Review 10.  Common emergencies in cancer medicine: cardiovascular and neurologic syndromes.

Authors:  C R Thomas; E A Edmondson
Journal:  J Natl Med Assoc       Date:  1991-11       Impact factor: 1.798

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.